Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by Hedgefundharryon Feb 19, 2019 6:53am
199 Views
Post# 29380921

Comparing Aurora’s vs. Canopy’s

Comparing Aurora’s vs. Canopy’s



Per Financial Statements for period Oct 1-Dec 31, 2018 ACB CGC ( in 

 

Item.................................................................ACB........................ CGC

 

Revenue from sale of goods..........................$59,411,000..............$97,703,000 

 

Revenue from provision of services ...............$2,589,000 ...............None...

 

Gross revenue................................................$62,000,000............$97,703,000

 

Excise taxes ................................................($7,822,000)............ ($14,655,000) 

 

Net revenue..................................................$54,178,000.............$83,048,000

 

Cost of sales.............................................. ($25,800,000)........... ($64,758,000) 

 

Gross profit before fair value adjustments... $28,378,000..............$18,290,000

 

Changes in fair value of inventory sold ........($21,620,000)............($28,105,000)

 

Unrealized gain on changes.........................$25,384,000 ..............$22,267,000

in fair value of biological assets

---------------------------------------------------------------------------------------------------------

 

*Gross Profit..................................................$32,142,000.................$12,452,000

--------------------------------------------------------------------------------------------------------

 

Expense :

 

General and administration..........................($43,621,000)............... ($46,088,000)

 

Sales and marketing ...................................($22,741,000)................ ($44,895,000)

 

Acquisition costs .........................................($5,692,000)....................($4,520,000)

 

Research and development........................ ($1,811,000)................... ($5,264,000)

 

Depreciation and amortization 9, 12 ..........($19,263,000)................... ($5,015,000)

 

Share-based compensation 16 (a), 16(b).. ($19,204,000).................... ($63,911,000)

-----------------------------------------------------------------------------------------------------------------

 

Total G&A .................................................($112,332,000).................... ($169,693,000)

 

*Loss from operations ................................. ($80,190,000).................... ($157,241,000)

 

let me say a few things 

1..this is just a small glimpse of three months of the two biggest Cannabis companies in the world

2.These numbers reflect operational numbers and do not include things like loses and gains from derivatives suck as

share loses 

 

when you go through this consider that since these results were published no analist has done this comparison ..I ask why ?

 

when you go through this consider that even though CGC had considerable more earnings in this quarter ACB made 2.5 X more gross profit ....again I ask why 

 

Lastly I know this is just a glimpse but I ask one last question ..should a company the is worth 20 billion dollars have 2.5 times less gross profit than a company that is worth 7 billion Dollars ..

and could the market be very wrong about the real value of CGC or maybe the real Value of ACB 

 

These are the numbers all can be found in their financial statements please download and confirm them 

 

just ask yourself ..WHY has no analyst seen this or are they not interested in the truth 

is Cramer that dense that he cannot see it that he still pumps CGC , 

Or does everyone see it and wants to buy cheap Aurora shares before they show it to the public 

glta

harry

 
Bullboard Posts